JP2012526542A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526542A5 JP2012526542A5 JP2012510415A JP2012510415A JP2012526542A5 JP 2012526542 A5 JP2012526542 A5 JP 2012526542A5 JP 2012510415 A JP2012510415 A JP 2012510415A JP 2012510415 A JP2012510415 A JP 2012510415A JP 2012526542 A5 JP2012526542 A5 JP 2012526542A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- seq
- acid sequence
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17765009P | 2009-05-12 | 2009-05-12 | |
| US61/177,650 | 2009-05-12 | ||
| US24463809P | 2009-09-22 | 2009-09-22 | |
| US61/244,638 | 2009-09-22 | ||
| PCT/IB2010/052056 WO2010131185A1 (en) | 2009-05-12 | 2010-05-10 | Blocking anti-dkk-1 antibodies and their uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012526542A JP2012526542A (ja) | 2012-11-01 |
| JP2012526542A5 true JP2012526542A5 (enExample) | 2013-06-20 |
Family
ID=42315893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510415A Ceased JP2012526542A (ja) | 2009-05-12 | 2010-05-10 | 遮断抗ｄｋｋ−１抗体およびその使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8338576B2 (enExample) |
| EP (1) | EP2430048A1 (enExample) |
| JP (1) | JP2012526542A (enExample) |
| KR (1) | KR101471239B1 (enExample) |
| CN (1) | CN102666584A (enExample) |
| AR (1) | AR076668A1 (enExample) |
| AU (1) | AU2010246981B2 (enExample) |
| BR (1) | BRPI1010540A2 (enExample) |
| CA (1) | CA2761696A1 (enExample) |
| CO (1) | CO6460768A2 (enExample) |
| IL (1) | IL216304A0 (enExample) |
| MX (1) | MX2011012039A (enExample) |
| NZ (1) | NZ596274A (enExample) |
| PE (1) | PE20120475A1 (enExample) |
| RU (1) | RU2548817C2 (enExample) |
| SA (1) | SA110310369B1 (enExample) |
| SG (1) | SG175881A1 (enExample) |
| TW (1) | TWI411444B (enExample) |
| WO (1) | WO2010131185A1 (enExample) |
| ZA (1) | ZA201108310B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8043620B2 (en) * | 2007-11-21 | 2011-10-25 | Amgen Inc. | Wise binding agents and epitopes |
| TWI636993B (zh) * | 2010-10-27 | 2018-10-01 | 安美基公司 | Ｄｋｋ１抗體及使用方法 |
| AR085091A1 (es) | 2011-01-26 | 2013-09-11 | Kolltan Pharmaceuticals Inc | Anticuerpos anti-kit y sus usos |
| US8852592B2 (en) | 2011-05-10 | 2014-10-07 | Biocare Medical, Llc | Systems and methods for anti-PAX8 antibodies |
| US10316103B1 (en) | 2012-03-30 | 2019-06-11 | Biocare Medical, Llc | Systems and methods for anti-Uroplakin III antibodies |
| SG11201500489YA (en) | 2012-07-25 | 2015-02-27 | Kolltan Pharmaceuticals Inc | Anti-kit antibodies and uses thereof |
| US9429577B2 (en) | 2012-09-27 | 2016-08-30 | Biocare Medical, Llc | Anti-uroplakin II antibodies systems and methods |
| US10429390B2 (en) | 2012-12-18 | 2019-10-01 | Biocare Medical, Llc | Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer |
| EP2962113B1 (en) | 2013-02-28 | 2019-04-03 | Biocare Medical, LLC | Anti-p40 antibodies systems and methods |
| GB201312638D0 (en) * | 2013-07-15 | 2013-08-28 | King S College London | Biomarkers |
| DK3052522T3 (da) | 2013-10-03 | 2020-02-24 | Biocare Medical Llc | Anti-sox 10 antistofsystemer og -fremgangsmåder |
| CN106659782B (zh) | 2014-05-23 | 2021-11-09 | 塞尔德克斯医疗公司 | 一种用于嗜酸性粒细胞或肥大细胞相关病症治疗的抗体 |
| AU2016263030A1 (en) | 2015-05-18 | 2017-10-12 | Eli Lilly And Company | Anti-Dkk-1-anti-RANKL bispecific antibody compounds |
| EP4640703A2 (en) | 2017-11-14 | 2025-10-29 | Chugai Seiyaku Kabushiki Kaisha | Anti-c1s antibodies and methods of use |
| WO2019213285A1 (en) * | 2018-05-02 | 2019-11-07 | Ortheus, Inc. | Systems and methods for local modulation of wnt signaling |
| BR112021021689A2 (pt) | 2019-05-15 | 2022-03-22 | Chugai Pharmaceutical Co Ltd | Molécula de ligação a antígeno, composição farmacêutica, e método |
| CN112180094A (zh) * | 2019-07-04 | 2021-01-05 | 上海东慈生物科技有限公司 | Dkk1抑制剂在预防和/或治疗肿瘤恶病质与糖尿病伴随疾病中的应用 |
| KR102192471B1 (ko) * | 2019-10-18 | 2020-12-17 | 주식회사 인코스팜 | 탈모 완화 및 모발 성장을 촉진시키는 펩타이드 및 이를 포함하는 화장료 조성물 |
| KR102494042B1 (ko) * | 2020-11-20 | 2023-02-07 | 주식회사 하울바이오 | 인간모유두세포의 성장을 촉진하는 항-dkk-1 항체 및 이의 용도 |
| CN112592402B (zh) * | 2020-12-02 | 2022-04-26 | 杭州奕安济世生物药业有限公司 | 抗dkk2抗体、包含该抗dkk2抗体的组合物及其用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7057017B2 (en) | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| US6391311B1 (en) | 1998-03-17 | 2002-05-21 | Genentech, Inc. | Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1 |
| DE19747418C1 (de) | 1997-10-27 | 1999-07-15 | Deutsches Krebsforsch | Inhibitor-Protein des wnt-Signalwegs |
| US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
| DK1490386T3 (da) | 1998-03-10 | 2008-12-15 | Genentech Inc | Nyt polypeptid og nukleinsyrer kodende for dette |
| US6962797B2 (en) | 1998-04-15 | 2005-11-08 | Genentech, Inc. | Nucleic acids encoding PRO615 |
| US6344541B1 (en) | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
| US20030203446A1 (en) | 1998-10-07 | 2003-10-30 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6673549B1 (en) | 2000-10-12 | 2004-01-06 | Incyte Corporation | Genes expressed in C3A liver cell cultures treated with steroids |
| AU2002306505B2 (en) | 2001-02-16 | 2007-02-15 | Genentech, Inc. | Treatment involving DKK-1 or antagonists thereof |
| US20040038860A1 (en) | 2002-05-17 | 2004-02-26 | Allen Kristina M. | Reagents and methods for modulating dkk-mediated interactions |
| CA2446582A1 (en) * | 2001-05-17 | 2002-11-21 | Genome Therapeutics Corporation | Reagents and methods for modulating dkk-mediated interactions |
| EP1461448A2 (en) | 2001-11-07 | 2004-09-29 | The Board Of Trustees Of The University Of Arkansas | Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| US7371736B2 (en) | 2001-11-07 | 2008-05-13 | The Board Of Trustees Of The University Of Arkansas | Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss |
| US7894992B2 (en) | 2001-11-07 | 2011-02-22 | Board Of Trustees Of The University Of Arkansas | Diagnosis and classification of multiple myeloma |
| US7308364B2 (en) | 2001-11-07 | 2007-12-11 | The University Of Arkansas For Medical Sciences | Diagnosis of multiple myeloma on gene expression profiling |
| PT1913952E (pt) | 2002-12-05 | 2011-04-14 | Univ Arkansas | Determinantes moleculares da doença óssea do mieloma e respectivas utilizações |
| US7642238B2 (en) | 2002-12-05 | 2010-01-05 | Shaughnessy John D | Molecular determinants of myeloma bone disease and uses thereof |
| US8124087B2 (en) | 2002-12-05 | 2012-02-28 | Board Of Trustees Of The University Of Arkansas | Methods of controlling bone loss by inhibiting DKK1 |
| US7811750B2 (en) | 2002-12-05 | 2010-10-12 | Board Of Trustees Of The University Of Arkansas | Molecular determinants of myeloma bone disease and use thereof |
| US20050084494A1 (en) | 2003-05-21 | 2005-04-21 | Darwin Prockop | Inhibitors of Dkk-1 |
| US8637506B2 (en) | 2003-09-22 | 2014-01-28 | Enzo Biochem, Inc. | Compositions and methods for bone formation and remodeling |
| US8343922B2 (en) | 2004-05-19 | 2013-01-01 | Enzo Biochem, Inc. | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| ES2414460T3 (es) | 2004-08-04 | 2013-07-19 | Amgen Inc. | Anticuerpos para Dkk-1 |
| AR060017A1 (es) * | 2006-01-13 | 2008-05-21 | Novartis Ag | Composiciones y metodos de uso para anticuerpos de dickkopf -1 |
| WO2008070112A1 (en) | 2006-12-06 | 2008-06-12 | The Board Of Trustees Of The University Of Arkansas | Overexpression of wnt ligands and treatment of lytic bone diseases |
| EP2121755A1 (en) | 2007-02-08 | 2009-11-25 | Merck & Co., Inc. | Antibodies specific for dkk-1 |
| AR075989A1 (es) | 2009-04-10 | 2011-05-11 | Lilly Co Eli | Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria |
-
2010
- 2010-05-10 PE PE2011001952A patent/PE20120475A1/es not_active Application Discontinuation
- 2010-05-10 BR BRPI1010540A patent/BRPI1010540A2/pt not_active IP Right Cessation
- 2010-05-10 JP JP2012510415A patent/JP2012526542A/ja not_active Ceased
- 2010-05-10 CA CA2761696A patent/CA2761696A1/en not_active Abandoned
- 2010-05-10 RU RU2011145435/10A patent/RU2548817C2/ru not_active IP Right Cessation
- 2010-05-10 SA SA110310369A patent/SA110310369B1/ar unknown
- 2010-05-10 EP EP10721057A patent/EP2430048A1/en not_active Ceased
- 2010-05-10 MX MX2011012039A patent/MX2011012039A/es active IP Right Grant
- 2010-05-10 WO PCT/IB2010/052056 patent/WO2010131185A1/en not_active Ceased
- 2010-05-10 NZ NZ596274A patent/NZ596274A/xx not_active IP Right Cessation
- 2010-05-10 KR KR1020117029598A patent/KR101471239B1/ko not_active Expired - Fee Related
- 2010-05-10 CN CN2010800316466A patent/CN102666584A/zh active Pending
- 2010-05-10 SG SG2011081080A patent/SG175881A1/en unknown
- 2010-05-10 AU AU2010246981A patent/AU2010246981B2/en not_active Ceased
- 2010-05-10 AR ARP100101589A patent/AR076668A1/es unknown
- 2010-05-11 TW TW099115010A patent/TWI411444B/zh not_active IP Right Cessation
- 2010-05-11 US US12/777,806 patent/US8338576B2/en not_active Expired - Fee Related
-
2011
- 2011-11-10 IL IL216304A patent/IL216304A0/en unknown
- 2011-11-11 ZA ZA2011/08310A patent/ZA201108310B/en unknown
- 2011-11-15 CO CO11155162A patent/CO6460768A2/es active IP Right Grant
-
2012
- 2012-11-19 US US13/680,569 patent/US8586721B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012526542A5 (enExample) | ||
| JP2012116856A5 (enExample) | ||
| RU2016129274A (ru) | Канинизированные мышиные антитела к человеческому pd-1 | |
| JP2018521638A5 (enExample) | ||
| RU2016107814A (ru) | Новое антитело к tslp-рецептору человека | |
| RU2011145435A (ru) | БЛОКИРУЮЩИЕ АНТИТЕЛА ПРОТИВ Dkk-1 И ИХ ПРИМЕНЕНИЯ | |
| JP2011528901A5 (enExample) | ||
| JP2013502204A5 (enExample) | ||
| JP2010502207A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2018536393A5 (enExample) | ||
| JP2014205674A5 (enExample) | ||
| RU2017134495A (ru) | Антитела к альфа-рецептору собачьего интерлейкина-4 | |
| JP2012107017A5 (enExample) | ||
| JP2016196468A5 (enExample) | ||
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| JP2014526898A5 (enExample) | ||
| JP2016516400A5 (enExample) | ||
| JP2010511388A5 (enExample) | ||
| JP2011173884A5 (enExample) | ||
| JP2009225799A5 (enExample) | ||
| WO2016207304A3 (en) | Monoclonal anti-il-1racp antibodies | |
| JP2018504105A5 (enExample) | ||
| JP2010536384A5 (enExample) | ||
| JP2011527902A5 (enExample) |